Potential role of MAD1 1673G>A and ERCC1 8092C>A polymorphisms in the resistance to chemotherapy in advanced ovarian cancer: A pilot study.

Irwin Alejandro Hernandez Cruz,Diddier G. Prada,José Díaz-Chávez,Salim Abraham Barquet Muñoz,David Cantú-de-León,Luis A. Herrera

Potential role of MAD1 1673G>A and ERCC1 8092C>A polymorphisms in the resistance to chemotherapy in advanced ovarian cancer: A pilot study.

2017

Irwin Alejandro Hernandez Cruz
Diddier G. Prada
José Díaz-Chávez
Salim Abraham Barquet Muñoz
David Cantú-de-León
Luis A. Herrera

e17045Background: Ovarian cancer (OC) is the most lethal gynecological cancer and 70% of cases are in advanced stages at diagnosis. The standard treatment for those stages is optimal cytoreduction ...

Keywords:

Ovarian cancer
ERCC1
Pathology
Medicine
Chemotherapy
Standard treatment
advanced ovarian cancer
Oncology
advanced stage
Internal medicine
gynecological cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations